These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27036555)

  • 1. TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.
    Watson G; O'Hara J; Carding P; Lecouturier J; Stocken D; Fouweather T; Wilson J
    Trials; 2016 Apr; 17():175. PubMed ID: 27036555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT.
    Wilson JA; Stocken DD; Watson GC; Fouweather T; McGlashan J; MacKenzie K; Carding P; Karagama Y; Harries M; Ball S; Khwaja S; Costello D; Wood R; Lecouturier J; O'Hara J
    Health Technol Assess; 2021 Jan; 25(3):1-118. PubMed ID: 33492208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial.
    O'Hara J; Stocken DD; Watson GC; Fouweather T; McGlashan J; MacKenzie K; Carding P; Karagama Y; Wood R; Wilson JA
    BMJ; 2021 Jan; 372():m4903. PubMed ID: 33414239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nissen fundoplication
    Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
    World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the quality of life of patients with laryngopharyngeal reflux after treatment.
    Lee JS; Lee YC; Kim SW; Kwon KH; Eun YG
    J Voice; 2014 Jul; 28(4):487-91. PubMed ID: 24598356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of anti-reflux surgery on refractory laryngopharyngeal reflux disease in professional voice users: a pilot study.
    Weber B; Portnoy JE; Castellanos A; Hawkshaw MJ; Lurie D; Katz PO; Sataloff RT
    J Voice; 2014 Jul; 28(4):492-500. PubMed ID: 24629640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
    Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal pH Testing Does Not Predict Response to Proton Pump Inhibitor Therapy in Patients with Laryngeal Symptoms.
    Yadlapati R; Pandolfino JE; Lidder AK; Shabeeb N; Jaiyeola DM; Adkins C; Agrawal N; Cooper A; Price CP; Ciolino JD; Gawron AJ; Smith SS; Bove M; Tan BK
    Am J Gastroenterol; 2016 Nov; 111(11):1517-1524. PubMed ID: 27091320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial.
    Shen H; Han Y; Wu D; Hu L; Ma Y; Wu F; Tao Y; Liu Y
    Trials; 2022 Apr; 23(1):272. PubMed ID: 35395946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Proton Pump Inhibitor on the Outcome of Laryngeal Microsurgery in Patients With Vocal Fold Mucosal Disease With Reflux Symptoms.
    Bang JH; Lee SG; Kwon KJ; Lee SA; Eun YG; Lee YC
    J Voice; 2024 Jul; 38(4):931-935. PubMed ID: 35153121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors for the treatment of laryngopharyngeal reflux disease: A protocol for systematic review and meta-analysis.
    Liu X; Jiang Y; Luo H; Liu H
    Medicine (Baltimore); 2020 Dec; 99(49):e23297. PubMed ID: 33285706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Mixed-Methods Study of Patient Views on Reflux Symptoms and Medication Routines.
    Pisegna JM; Yang S; Purcell A; Rubio A
    J Voice; 2017 May; 31(3):381.e15-381.e25. PubMed ID: 27647519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of voice therapy and antireflux therapy rapidly recovers voice-related symptoms in laryngopharyngeal reflux patients.
    Park JO; Shim MR; Hwang YS; Cho KJ; Joo YH; Cho JH; Nam IC; Kim MS; Sun DI
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):92-7. PubMed ID: 21908799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease.
    Andreasson A; Agréus L; Mastellos N; Bliźniuk G; Waśko-Czopnik D; Angelaki A; Theodosaki E; Lionis C; Hek K; Verheij R; Wright E; Durbaba S; Muris J; Bródka P; Saganowski S; Ethiér JF; Curcin V; Delaney B
    Ann Med; 2024 Dec; 56(1):2354683. PubMed ID: 38753973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vocal Tract Discomfort and Dysphonia in Patients Undergoing Empiric Therapeutic Trial with Proton Pump Inhibitor for Suspected Laryngopharyngeal Reflux.
    Mozzanica F; Robotti C; Lechien JR; Pizzorni N; Pirola F; Mengucci A; Dell'Era A; Ottaviani F; Schindler A
    J Voice; 2020 Mar; 34(2):280-288. PubMed ID: 30563730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are persistent throat symptoms atypical features of gastric reflux and should they be treated with proton pump inhibitors?
    Powell J; O'Hara J; Wilson JA
    BMJ; 2014 Oct; 349():g5813. PubMed ID: 25300569
    [No Abstract]   [Full Text] [Related]  

  • 17. Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux.
    Wilkie MD; Fraser HM; Raja H
    Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2515-2521. PubMed ID: 30062580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflux finding score and reflux symptom index as potential predictors for proton pump inhibitor response in globus pharyngeus patients: A prospective study.
    Boom L; Edens M; Rinia B
    Auris Nasus Larynx; 2020 Aug; 47(4):609-615. PubMed ID: 32113831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight weeks of omeprazole 20 mg significantly reduces both laryngopharyngeal reflux and comorbid chronic rhinosinusitis signs and symptoms: Randomised, double-blind, placebo-controlled trial.
    Anzić SA; Turkalj M; Župan A; Labor M; Plavec D; Baudoin T
    Clin Otolaryngol; 2018 Apr; 43(2):496-501. PubMed ID: 29024410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voice Quality as Therapeutic Outcome in Laryngopharyngeal Reflux Disease: A Prospective Cohort Study.
    Lechien JR; Finck C; Huet K; Fourneau AF; Khalife M; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
    J Voice; 2020 Jan; 34(1):112-120. PubMed ID: 30220528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.